He has covered insurance for a decade, including auto, home, life and health. Before cove... Ashlee is an insurance editor, journalist and business professional with an MBA and more than 17 years ...

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $405.4 which represents a decrease of $-5.84 or -1.42% from the prior close of $411.24. The stock opened at $410.18 and touched a low ...

Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ServiceNow, Inc. (NOW), Alibaba Group ...

The share of in-network federal health insurance exchange plan claims denied in 2023 was the highest since 2015, according to ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...